The COVID-19 pandemic created ripple effects across all of health care, especially for at-risk populations like cancer patients. Early in the pandemic, the National Cancer Institute initiated a study to examine the intersection of cancer and COVID-19 diagnoses. More than two years later, we discuss with NCI Head of Breast Cancer and Melanoma Therapeutics Dr. Larissa Korde from the Clinical Investigations Branch on the status of the study, some of the preliminary findings and how it’s evolved.
Cancer HealthCast
26m listen
A Look Into COVID-19’s Impact on Cancer Patients
Share
An NCI study examines the crossroads between cancer and COVID-19 diagnoses.
-
Dr. Larissa Korde Head, Breast Cancer and Melanoma Therapeutics NCI
Related Content
-
Flipping the Script on AI Adoption at Space Force
The newest military service is moving away from off-the-shelf solutions to build a culture of internal innovation and mission-specific tools.
10m watch -
Introducing Technically Zen, an Upcoming Podcast on Wellness in Tech
A preview episode introducing Technically Zen, a new podcast exploring well-being, leadership and resilience for federal technologists.
16m listen -
NASA Transforms Agency Culture to Harness AI for Next-Generation Space Missions
The agency’s AI leader Krista Kinnard discussed how AI is impacting spacecraft design, human resources and more.
7m watch -
What’s Coming in Federal IT in 2026
Agency leaders are operationalizing AI and modernizing legacy software to meet the demands of a changing government landscape.
6m listen